<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1" specific-use="sps-1.9" article-type="review-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">abcimg</journal-id>
<journal-title-group>
<journal-title>ABC Imagem Cardiovascular</journal-title>
<abbrev-journal-title abbrev-type="publisher">Arq Bras Cardiol: Imagem cardiovasc.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2675-312X</issn>
<publisher>
<publisher-name>Sociedade Brasileira de Cardiologia</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.36660/abcimg.20240104i</article-id>
<article-id pub-id-type="publisher-id">abcimg.20240104i</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Left Ventricular Strain in Heart Failure with Preserved Ejection Fraction: A Fast Dive into Diagnosis, Response to Exercise and Afterload Challenge</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0003-0031-335X</contrib-id>
<name><surname>Hortegal</surname><given-names>Renato A.</given-names></name>
<role>Conception and design of the research</role>
<role>acquisition of data</role>
<role>writing of the manuscript</role>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">0000-0002-1919-164X</contrib-id>
<name><surname>Bihan</surname><given-names>David Le</given-names></name>
<role>Conception and design of the research</role>
<role>acquisition of data</role>
<role>writing of the manuscript</role>
<role>critical revision of the manuscript for intellectual content</role>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c1"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mathias</surname><given-names>Mariana Mendes</given-names></name>
<role>Conception and design of the research</role>
<role>writing of the manuscript</role>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-0890-5870</contrib-id>
<name><surname>Barretto</surname><given-names>Rodrigo</given-names></name>
<role>critical revision of the manuscript for intellectual content</role>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mathias</surname><given-names>Wilson</given-names><suffix>Jr</suffix></name>
<role>critical revision of the manuscript for intellectual content</role>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<aff id="aff1">
<label>1</label>
<institution content-type="orgname">Universidade de São Paulo</institution>
<institution content-type="orgdiv1">Instituto do Coração</institution>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Universidade de São Paulo, Instituto do Coração, São Paulo, SP - Brazil</institution>
</aff>
<aff id="aff2">
<label>2</label>
<institution content-type="orgname">Grupo Fleury</institution>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Grupo Fleury, São Paulo, SP - Brazil</institution>
</aff>
<aff id="aff3">
<label>3</label>
<institution content-type="orgname">Hospital das Clínicas FMUSP</institution>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brazil</country>
<institution content-type="original">Hospital das Clínicas FMUSP, São Paulo, SP - Brazil</institution>
</aff>
</contrib-group>
<author-notes>
<corresp id="c1"><label>Mailing Address: David Le Bihan •</label> Instituto do Coração (InCor), Hospital das Clínicas da Faculdade de Medicina da USP. Av. Dr. Enéas Carvalho de Aguiar, 44. Postal code: <postal-code>05403-900</postal-code>. Cerqueira César, Sao Paulo, SP - Brazil E-mail: <email>david.bihan@hc.fm.usp.br</email></corresp>
<fn fn-type="conflict"><label>Potential Conflict of Interest</label> <p>No potential conflict of interest relevant to this article was reported.</p></fn>
<fn fn-type="edited-by"><label>Editor responsible for the review:</label> <p>Marcelo Tavares</p></fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub">
<day>16</day>
<month>12</month>
<year>2024</year></pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2024</year></pub-date>
<volume>37</volume>
<issue>4</issue>
<elocation-id>e20240104</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>10</month>
<year>2024</year></date>
<date date-type="accepted">
<day>28</day>
<month>10</month>
<year>2024</year>
</date>
</history>
<permissions>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/" xml:lang="en">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License</license-p>
</license>
</permissions>
<abstract>
<title>Abstract</title>
<p>Heart Failure with Preserved Ejection Fraction (HFpEF) is an increasing challenge in cardiology, marked by impairments in systolic and/or diastolic function. HFpEF patients often present with exercise intolerance, yet diagnosis is complicated by overlapping comorbidities, such as obesity and hypertension. Left ventricular Global Longitudinal Strain (GLS) enables the detection of subtle systolic dysfunction, with studies indicating a stronger correlation between GLS and exercise capacity than ejection fraction (EF). In exercise echocardiography, GLS displays a characteristic bimodal pattern due to hemodynamic adaptations, with deviations suggesting HFpEF. When exercise testing is unfeasible or when a specific evaluation of ventricular-arterial coupling is desired, an afterload challenge offers a controlled alternative by increasing systemic resistance. Beyond GLS, mechanical dispersion (MD) measures contractile heterogeneity, while left atrial strain (LAS) has shown promise in identifying atrial dysfunction linked to HFpEF. These parameters, evaluated alongside E/e&apos; ratios and pulmonary systolic pressure during exercise, enhance HFpEF diagnosis, provide a more comprehensive view of the syndrome&apos;s pathophysiology, and offer insights to support treatment.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Heart Failure</kwd>
<kwd>Echocardiography</kwd>
<kwd>Exercise</kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="31"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Heart Failure with Preserved Ejection Fraction (HFpEF) is a major public health disorder, accounting for at least 50% of all heart failure patients, with an increasing prevalence.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> It represents a significant unmet need in cardiology, with considerable knowledge gaps regarding its pathophysiology, natural history, diagnosis, and treatment.<sup><xref ref-type="bibr" rid="B1">1</xref></sup></p>
<p>The primary complaint of HFpEF patients is exercise intolerance. However, accurately assessing this symptom solely based on patient-reported outcomes can be challenging. The typical HFpEF phenotype, often referred to as "Garden Variety HFpEF" (an English term describing something ordinary or standard, lacking exceptional characteristics), typically includes at least four comorbidities, such as obesity, hypertension, atrial fibrillation, and kidney disease. These comorbidities complicate the differential diagnosis, making it difficult to distinguish between reduced exercise capacity caused by the comorbid conditions and the heart failure syndrome itself.<sup><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref></sup> Additionally, many patients exhibit clinical presentations without signs of fluid overload on physical examination, making the classical Framingham criteria less sensitive for recognizing these patients.<sup><xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref></sup></p>
<p>In this context, echocardiography plays a crucial role in evaluating patients with suspected HFpEF, and strain imaging can indeed provide critical information to improve diagnostic performance.<sup><xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref></sup> HFpEF has traditionally been associated with severe diastolic dysfunction leading to "backward failure" and pulmonary congestion, which limits exercise capacity.<sup><xref ref-type="bibr" rid="B7">7</xref></sup> While diastolic dysfunction is undeniably key in HFpEF pathophysiology, other abnormalities, including subtle systolic dysfunction despite preserved ejection fraction (EF), also play an important role.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref></sup> Using left ventricular Global Longitudinal Strain (GLS) allows us to assess these subtle systolic impairments.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
<sec>
<title>Left Ventricular GLS as a Diagnostic Criterion for HFpEF</title>
<p>The technical requirements for obtaining high-quality GLS have been detailed in the guidelines.<sup><xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup> The normal range of GLS is between 18% to 22% (modular values), with values between 16% to 18% considered borderline. GLS values below 16% are indicative of systolic dysfunction.<sup><xref ref-type="bibr" rid="B11">11</xref></sup></p>
<p>The score proposed by the European Society of Cardiology (HFA-PEFF)<sup><xref ref-type="bibr" rid="B12">12</xref></sup> includes GLS as one feature in the functional domain, along with measurements from the structural (morphological domain) and biomarkers (natriuretic peptides) domains (<xref ref-type="fig" rid="f1">Figure 1</xref>). This approach is important as it guides the physician to interpret GLS in the context of these other features for the diagnosis of HFpEF.</p>
<fig id="f1">
<label>Figure 1</label>
<caption><title>The HFA-PEFF score for the diagnosis of HFpEF. HFA-PEFF score to evaluate the diagnosis of HFpEF. HFA-PEFF: Heart Failure Association-PEFF; NP: natriuretic peptide; e&apos;: early diastolic mitral annular velocity; E: early transmitral flow velocity; TRV: tricuspid regurgitation velocity; GLS: left ventricular global longitudinal strain; LAVI: left atrial volume index; LVMI: left ventricular mass index; RWT: relative wall thickness; LV: left ventricle; SR: sinus rhythm; NT-pro-BNP: N-terminal pro-B-type natriuretic peptide; BNP: B-type natriuretic peptide; AF: atrial fibrillation. *Values should adjust to e&apos;&lt;5cm/s and e&apos; lateral&lt;7cm/s if patients has age&gt;75years/old.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-gf01.tif"/>
</fig>
<p>Evaluating GLS in conjunction with other features is crucial, as an abnormal GLS has been associated with various clinical conditions known to impair the myocardium, such as hypertension, diabetes mellitus, aortic stenosis, and amyloidosis. These conditions may act as risk factors or HFpEF mimics.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup></p>
<p>Abnormalities in GLS without other pathophysiological impairments may not fulfill all conditions to increase filling pressures and cause HFpEF syndrome. Indeed, other studies have shown that GLS only moderately correlates with filling pressures.<sup><xref ref-type="bibr" rid="B14">14</xref></sup> Conversely, previous studies indicate that overt HFpEF can occur without impaired resting GLS, suggesting that using GLS in isolation may have sub-optimal sensitivity.<sup><xref ref-type="bibr" rid="B11">11</xref></sup></p>
<p>Nonetheless, there is evidence that GLS may have a significant role in the physiological cardiocirculatory adaptations that determine exercise capacity. A recent meta-analysis of 25 studies, comprising 2136 patients with preserved and reduced EF, demonstrated that both GLS and EF have a linear relationship with peak oxygen uptake (VO2). However, the correlation between VO2 and GLS was twice as strong as the correlation between VO2 and EF.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> These findings highlight the relevance of strain imaging features in assessing the cardiocirculatory components of exercise intolerance.</p>
</sec>
<sec>
<title>Left Ventricular GLS in Exercise Echocardiography</title>
<p>Patients with HFpEF may exhibit functional abnormalities primarily during hemodynamic overload, with the exercise test using a cycle ergometer being the preferred modality for inducing such stress.<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref></sup> Assessing GLS during exercise is, therefore, logical and has significant potential to enhance the diagnostic accuracy for HFpEF.</p>
<p>It is crucial to recognize that GLS is a load-sensitive parameter,<sup><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup> and its behavior during exercise must be interpreted in the context of the physiological adaptations occurring at different exercise phases. During the initial phases of exercise, cardiac output increases due to elevated preload and cardiac contraction, leading to a rise in stroke volume. At this stage, GLS typically improves compared to resting conditions. In the subsequent phase, around the ventilatory anaerobic threshold, stroke volume tends to plateau, and further increases in cardiac output are achieved through an elevated heart rate, which reduces preload and consequently lowers GLS.<sup><xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref></sup> Thus, GLS demonstrates a characteristic bimodal pattern during exercise (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
<fig id="f2">
<label>Figure 2</label>
<caption><title>Bimodal Behavior of GLS during exercise. GLS: Global Longitudinal Strain; VAT: Ventilatory Anaerobic Threshold.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-gf02.tif"/>
</fig>
<p>Despite that, there is a notable gap in research concerning how pathological deviations in HFpEF might affect or alter GLS patterns during exercise.</p>
</sec>
<sec>
<title>Trade-Off Between Frame Rate and Heart Rate During Exercise</title>
<p>One of the key technical considerations when assessing GLS during exercise echocardiography is the trade-off between frame rate and heart rate. As the heart rate increases during exercise, the cardiac cycle shortens, necessitating a higher frame rate to capture sufficient detail of myocardial motion throughout the cycle. High frame rates are crucial for accurately tracking myocardial deformation, especially at higher heart rates.<sup><xref ref-type="bibr" rid="B20">20</xref></sup></p>
<p>However, achieving higher frame rates often involves compromising spatial resolution, which can impact the accuracy of strain measurements.<sup><xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref></sup> Additionally, maintaining high frame rates can be technically challenging due to the need for high temporal resolution while ensuring image quality remains adequate for precise tracking.</p>
<p>Optimizing frame rate during exercise echocardiography is essential to balance the need for detailed temporal resolution and the limitations of spatial resolution. An inadequate frame rate can lead to under-sampling of myocardial motion, resulting in inaccurate GLS measurements and potential misinterpretation of myocardial function.<sup><xref ref-type="bibr" rid="B20">20</xref></sup></p>
<p>In clinical practice, it&apos;s essential to adjust ultrasound settings dynamically during exercise to maintain optimal frame rates as heart rates increase. This dynamic adjustment helps ensure that GLS measurements remain reliable and reflective of true myocardial performance under exercise conditions. For an accurate evaluation of peak longitudinal and peak circumferential strain, a proportion of 30 frames per cardiac cycle is recommended. This means that the minimum frame rate must be adjusted to ensure that at least 30 frames are captured during each cardiac cycle to provide reliable strain measurements. For instance, for a heart rate of 80 bpm, the minimum frame rate would be &gt; 40 fps, while for a heart rate of 160 bpm, the minimum frame rate would be &gt; 85 fps. From a practical point of view, it is recommended to aim to maintain a frame rate above 70% of the heart rate. Of note, this does not apply to the evaluation of the isovolumic phases, where frame rates as high as 500 fps would be required, which is an area to be explored with the new algorithms of high-frame-rate speckle tracking imaging.</p>
</sec>
<sec>
<title>Left Ventricular GLS in Afterload Challenge</title>
<p>In certain clinical settings or due to technical limitations, patients may be unable to undergo standard exercise tests. In such cases, alternative stress modalities, such as preload or afterload challenge, can provide valuable insights into myocardial function.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> An afterload challenge involves inducing pressure overload to assess myocardial performance under conditions of increased systemic resistance. This can be achieved through various methods, including:</p>
<list list-type="simple">
<list-item><label>–</label> <p><bold>Handgrip Exercise:</bold> The patient squeezes a handgrip dynamometer, which generates sustained isometric muscle contractions. This method induces an increase in systemic vascular resistance.</p></list-item>
<list-item><label>–</label> <p><bold>Limbs Constriction:</bold> This involves applying external pressure to the limbs using cuffs or bands to create a controlled resistance against blood flow. The resulting increase in systemic resistance provides a measurable afterload challenge.</p></list-item>
</list>
<p>These methods can be used either individually or in combination. Afterload challenges may offer distinct advantages over standard dynamic exercise, as they induce a controlled hemodynamic overload without significantly raising heart and respiratory rates. This leads to less noise in echocardiographic signals, thereby enhancing the accuracy of advanced deformation imaging.</p>
<p>Nonetheless, it is important to recognize the fundamental differences between standard dynamic exercise and afterload challenge. Standard dynamic exercise primarily induces a "forward perturbation," which sequentially increases central venous pressure, pulmonary artery wedge pressure, left atrial preload, and the left atrium-left ventricle (LA-LV) gradient, raising the mitral E wave. This type of stress challenges the left ventricle (LV) to enhance the velocity of relaxation (e&apos;), thereby assessing diastolic reserve.</p>
<p>In contrast, an afterload challenge creates a "backward perturbation" by increasing systemic resistance, which reduces the velocity of LV relaxation. This results in lower e&apos; velocities and a diminished LA-LV gradient (lower mitral E wave). Consequently, echocardiographic features such as the E/e&apos; ratio exhibit different behavior under this type of stress, often without a significant increase. The normal ventricular response to increased afterload typically involves a reduction in the velocity and extent of ventricular contraction, leading to a compensatory increase in preload and activation of the Frank-Starling mechanism for heart contraction. Notably, LV longitudinal function assessed through strain imaging appears particularly sensitive to these contraction changes.<sup><xref ref-type="bibr" rid="B4">4</xref></sup></p>
<p>Studies investigating GLS during hemodynamic stress induced by afterload challenge can provide significant insights.<sup><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B24">24</xref></sup> Recent data has highlighted myocardial dysfunction related to increased afterload in patients with HFpEF, who initially exhibit preserved resting GLS (<xref ref-type="fig" rid="f3">Figure 3</xref>).<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref></sup></p>
<fig id="f3">
<label>Figure 3</label>
<caption><title>The Behavior of GLS during the Afterload Challenge and the increased afterload mediated systolic dysfunction. HFpEF: Heart Failure with Preserved Ejection Fraction.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-gf03.tif"/>
</fig>
<p>Therefore, the afterload challenge presents characteristics that make it the modality of choice to study changes in myocardial deformation and ventricular-arterial coupling during stress.</p>
</sec>
<sec>
<title>Left Ventricular Strain Beyond GLS: The Role of Mechanical Dispersion</title>
<p>The GLS measures the average amount of longitudinal contraction performed by the LV from the onset of isovolumetric contraction to the end of ventricular ejection. Consequently, valuable information about other phases of the cardiac cycle, such as isovolumetric relaxation, is not captured by GLS.<sup><xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref></sup> While GLS provides an accurate quantification of ventricular contraction, it does not qualitatively explain how the contraction is performed.</p>
<p>Mechanical dispersion (MD) is a strain feature that expresses the degree of temporal heterogeneity of contraction, serving as an indicator of mechanical dyssynchrony (<xref ref-type="fig" rid="f4">Figure 4</xref>).<sup><xref ref-type="bibr" rid="B25">25</xref></sup> Dyssynchrony has been established as an important characteristic of abnormal myocardial contraction in the context of conditions such as heart failure with reduced EF,<sup><xref ref-type="bibr" rid="B26">26</xref></sup> coronary artery disease,<sup><xref ref-type="bibr" rid="B27">27</xref></sup> hypertrophy, and HFpEF.<sup><xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref></sup></p>
<fig id="f4">
<label>Figure 4</label>
<caption><title>The Role of MD. On the left, the patient has an abnormal GLS and low MD. At right, a patient with the same value of GLS but displaying a high MD. GLS: Global Longitudinal Strain.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-gf04.tif"/>
</fig>
<p>The rationale for using this index in HFpEF is that, theoretically, a heterogeneous cardiac contraction, as stated by a high MD, leads to regional contractions that do not reach the reciprocal force from the opposite cardiac walls. Therefore, part of cardiac deformation will not be translated into an effective force to expel blood towards the aorta. Furthermore, dyssynchrony will affect both AV and VA coupling. This double hit in LV performance makes the heart more prone to higher increases in left atrium (LA) pressure during exercise adaptations such as increased preload and tachycardia. Thus, in the context of relatively preserved GLS, information on the synchronicity of contraction may help explain the subtle impairments observed in a subset of patients with HFpEF.</p>
<p>Recent data suggest that MD is more associated with exercise capacity in patients with pre-HFpEF and HFpEF when compared to GLS and other components of HFA-PEFF score, and it may provide new insights into how the heart could be more prone to the steep increase in filling pressures during exercise that characterizes this syndrome.<sup><xref ref-type="bibr" rid="B25">25</xref></sup></p>
<p>Currently, there is no precise cutoff for MD, but recent data indicate that values greater than 65 ms have high specificity for identifying subjects with a high probability of HFpEF.<sup><xref ref-type="bibr" rid="B25">25</xref></sup></p>
</sec>
<sec>
<title>Strain Imaging for Phenotyping HFpEF Syndrome</title>
<p>The patterns of different indices of strain imaging can help identify specific phenogroups within HFpEF.<sup><xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B30">30</xref></sup> Patients with HFpEF and reduced GLS (HFpEF-rLS) display contractile dysfunction, as well as myocardial abnormalities.</p>
<p>Conversely, 18-48% of HFpEF patients retain preserved GLS (HFpEF-pLS), yet they may still have other pathophysiological issues such as atrial dysfunction and pulmonary vascular disease.<sup><xref ref-type="bibr" rid="B30">30</xref></sup> In this group, Left atrial strain (LAS) is a promising biomarker for HFpEF and LA myopathy, enhancing diagnostic and prognostic insights.<sup><xref ref-type="bibr" rid="B31">31</xref></sup> Reduced LAS in HFpEF-pLS patients indicates significant LA impairment due to atrial cardiomyopathy, challenging the traditional notion that links LA disease solely to LV diastolic dysfunction. Combining GLS and LAS for HFpEF phenotyping provides a comprehensive understanding of cardiac impairments in these patients<sup><xref ref-type="bibr" rid="B11">11</xref></sup> (<xref ref-type="fig" rid="f5">Central Illustration</xref>).</p>
<fig id="f5">
<caption><title>Phenotyping Strategy for HFpEF. Based on the left ventricular strain, there are two distinct HFpEF phenotypes: HFpEF with reduced longitudinal systolic function (HFpEF-rLS) and HFpEF with preserved longitudinal systolic function (HFpEF-pLS). Integrating the LA strain reservoir (LASr) is suggested to introduce a comprehensive dimension that addresses impairments in both the LV and LA. Additionally, the potential inclusion of MD could further refine stratification.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-gf05.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusions">
<title>Final Messages</title>
<p>Despite the preserved EF, the compromise of systolic function, observed by the abnormalities in GLS and MD, and the impairment of atrial reservoir function demonstrated by a reduction in LAS, whether isolated or in association, support the diagnosis of HFpEF. Likewise, the lack of increasing GLS during physical exertion could be a sign of HFpEF. Besides, it is important to interpret these measures in conjunction with other echocardiographic data. An increase in E/e&apos; above 15, either alone or in combination with a rise in pulmonary artery systolic pressure above 60 mmHg during cicloergometer exercise, is a strong indicator of increased left ventricular filling pressures with exertion.<sup><xref ref-type="bibr" rid="B12">12</xref></sup> Despite this, there is still a lack of knowledge on how the hemodynamic information provided by Doppler should be interpreted alongside strain measurements. Finally, we still need to understand better how to interpret these findings in conjunction with the many clinical and laboratory variables that can be modified in HFpEF patients. Developing scores that integrate all these variables in different HFpEF phenotypes would be clinically relevant.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn1">
<label>Sources of Funding</label>
<p>There were no external funding sources for this study.</p></fn>
<fn fn-type="other" id="fn2">
<label>Study Association</label>
<p>This study is not associated with any thesis or dissertation work.</p></fn>
<fn fn-type="other" id="fn3">
<label>Ethics Approval and Consent to Participate</label>
<p>This article does not contain any studies with human participants or animals performed by any of the authors.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Kittleson</surname><given-names>MM</given-names></name>
<name><surname>Panjrath</surname><given-names>GS</given-names></name>
<name><surname>Amancherla</surname><given-names>K</given-names></name>
<name><surname>Davis</surname><given-names>LL</given-names></name>
<name><surname>Deswal</surname><given-names>A</given-names></name>
<name><surname>Dixon</surname><given-names>DL</given-names></name>
<etal/>
</person-group>
<article-title>2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee</article-title>
<source>J Am Coll Cardiol</source>
<year>2023</year>
<volume>81</volume>
<issue>18</issue>
<fpage>1835</fpage>
<lpage>1878</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2023.03.393</pub-id>
</element-citation>
<mixed-citation>Kittleson MM, Panjrath GS, Amancherla K, Davis LL, Deswal A, Dixon DL, et al. 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure with Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023;81(18):1835-78. doi: 10.1016/j.jacc.2023.03.393.</mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shah</surname><given-names>SJ</given-names></name>
<name><surname>Borlaug</surname><given-names>BA</given-names></name>
<name><surname>Kitzman</surname><given-names>DW</given-names></name>
<name><surname>McCulloch</surname><given-names>AD</given-names></name>
<name><surname>Blaxall</surname><given-names>BC</given-names></name>
<name><surname>Agarwal</surname><given-names>R</given-names></name>
<etal/>
</person-group>
<article-title>Research Priorities for Heart Failure with Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary</article-title>
<source>Circulation</source>
<year>2020</year>
<volume>141</volume>
<issue>12</issue>
<fpage>1001</fpage>
<lpage>1026</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.119.041886</pub-id>
</element-citation>
<mixed-citation>Shah SJ, Borlaug BA, Kitzman DW, McCulloch AD, Blaxall BC, Agarwal R, et al. Research Priorities for Heart Failure with Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary. Circulation. 2020;141(12):1001-26. doi: 10.1161/CIRCULATIONAHA.119.041886.</mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hortegal</surname><given-names>RA</given-names></name>
</person-group>
<article-title>Decoding the Diagnostic Dilemmas of Heart Failure with Preserved Ejection Fraction: Applying the Universal Definition for Enhanced Diagnosis Standardization</article-title>
<source>Arq Bras Cardiol: Imagem Cardiovasc</source>
<year>2023</year>
<volume>36</volume>
<issue>3</issue>
<comment>e20230074</comment>
<pub-id pub-id-type="doi">10.36660/abcimg.20230074</pub-id>
</element-citation>
<mixed-citation>Hortegal RA. Decoding the Diagnostic Dilemmas of Heart Failure with Preserved Ejection Fraction: Applying the Universal Definition for Enhanced Diagnosis Standardization. Arq Bras Cardiol: Imagem Cardiovasc. 2023;36(3):e20230074. doi: 10.36660/abcimg.20230074.</mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hortegal</surname><given-names>RA</given-names></name>
<name><surname>Valeri</surname><given-names>R</given-names></name>
<name><surname>Grizante</surname><given-names>M</given-names></name>
<name><surname>Cancellier</surname><given-names>R</given-names></name>
<name><surname>Uemoto</surname><given-names>V</given-names></name>
<name><surname>Gun</surname><given-names>C</given-names></name>
<etal/>
</person-group>
<article-title>Afterload Increase Challenge Unmasks Systolic Abnormalities in Heart Failure with Preserved Ejection Fraction</article-title>
<source>Int J Cardiol</source>
<year>2023</year>
<volume>380</volume>
<fpage>20</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijcard.2023.03.042</pub-id>
</element-citation>
<mixed-citation>Hortegal RA, Valeri R, Grizante M, Cancellier R, Uemoto V, Gun C, et al. Afterload Increase Challenge Unmasks Systolic Abnormalities in Heart Failure with Preserved Ejection Fraction. Int J Cardiol. 2023;380:20-7. doi: 10.1016/j.ijcard.2023.03.042.</mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Almeida</surname><given-names>ALC</given-names></name>
<name><surname>Melo</surname><given-names>MDT</given-names></name>
<name><surname>Bihan</surname><given-names>DCSL</given-names></name>
<name><surname>Vieira</surname><given-names>MLC</given-names></name>
<name><surname>Pena</surname><given-names>JLB</given-names></name>
<name><surname>Del Castillo</surname><given-names>JM</given-names></name>
<etal/>
</person-group>
<article-title>Position Statement on the Use of Myocardial Strain in Cardiology Routines by the Brazilian Society of Cardiology&apos;s Department Of Cardiovascular Imaging - 2023</article-title>
<source>Arq Bras Cardiol</source>
<year>2023</year>
<volume>120</volume>
<issue>12</issue>
<comment>e20230646</comment>
<pub-id pub-id-type="doi">10.36660/abc.20230646</pub-id>
</element-citation>
<mixed-citation>Almeida ALC, Melo MDT, Bihan DCSL, Vieira MLC, Pena JLB, Del Castillo JM, et al. Position Statement on the Use of Myocardial Strain in Cardiology Routines by the Brazilian Society of Cardiology&apos;s Department Of Cardiovascular Imaging - 2023. Arq Bras Cardiol. 2023;120(12):e20230646. doi: 10.36660/abc.20230646.</mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Barberato</surname><given-names>SH</given-names></name>
<name><surname>Romano</surname><given-names>MMD</given-names></name>
<name><surname>Beck</surname><given-names>ALS</given-names></name>
<name><surname>Rodrigues</surname><given-names>ACT</given-names></name>
<name><surname>Almeida</surname><given-names>ALC</given-names></name>
<name><surname>Assunção</surname><given-names>BMBL</given-names></name>
<etal/>
</person-group>
<article-title>Position Statement on Indications of Echocardiography in Adults - 2019</article-title>
<source>Arq Bras Cardiol</source>
<year>2019</year>
<volume>113</volume>
<issue>1</issue>
<fpage>135</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.5935/abc.20190129</pub-id>
</element-citation>
<mixed-citation>Barberato SH, Romano MMD, Beck ALS, Rodrigues ACT, Almeida ALC, Assunção BMBL, et al. Position Statement on Indications of Echocardiography in Adults - 2019. Arq Bras Cardiol. 2019;113(1):135-81. doi: 10.5935/abc.20190129.</mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>How to Diagnose Diastolic Heart Failure</collab>
</person-group>
<article-title>European Study Group on Diastolic Heart Failure</article-title>
<source>Eur Heart J</source>
<year>1998</year>
<volume>19</volume>
<issue>7</issue>
<fpage>990</fpage>
<lpage>1003</lpage>
<pub-id pub-id-type="doi">10.1053/euhj.1998.1057</pub-id>
</element-citation>
<mixed-citation>How to Diagnose Diastolic Heart Failure. European Study Group on Diastolic Heart Failure. Eur Heart J. 1998;19(7):990-1003. doi: 10.1053/euhj.1998.1057.</mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hortegal</surname><given-names>R</given-names></name>
<name><surname>Abensur</surname><given-names>H</given-names></name>
</person-group>
<article-title>Strain Echocardiography in Patients with Diastolic Dysfunction and Preserved Ejection Fraction: Are we Ready?</article-title>
<source>Arq Bras Cardiol: Imagem cardiovasc</source>
<year>2017</year>
<volume>30</volume>
<issue>4</issue>
<fpage>132</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.5935/2318-8219.20170034</pub-id>
</element-citation>
<mixed-citation>Hortegal R, Abensur H. Strain Echocardiography in Patients with Diastolic Dysfunction and Preserved Ejection Fraction: Are we Ready? Arq Bras Cardiol: Imagem cardiovasc. 2017;30(4):132-9. doi: 10.5935/2318-8219.20170034</mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>D&apos;Ávila</surname><given-names>LBO</given-names></name>
<name><surname>Lima</surname><given-names>ACGB</given-names></name>
<name><surname>Milani</surname><given-names>M</given-names></name>
<name><surname>Milani</surname><given-names>JGPO</given-names></name>
<name><surname>Cipriano</surname><given-names>GFB</given-names></name>
<name><surname>Le Bihan</surname><given-names>DCS</given-names></name>
<etal/>
</person-group>
<article-title>Left Ventricular Global Longitudinal Strain and Cardiorespiratory Fitness in Patients with Heart Failure: Systematic Review and Meta-Analysis</article-title>
<source>Hellenic J Cardiol</source>
<year>2024</year>
<volume>79</volume>
<fpage>58</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="doi">10.1016/j.hjc.2023.09.010</pub-id>
</element-citation>
<mixed-citation>D&apos;Ávila LBO, Lima ACGB, Milani M, Milani JGPO, Cipriano GFB, Le Bihan DCS, et al. Left Ventricular Global Longitudinal Strain and Cardiorespiratory Fitness in Patients with Heart Failure: Systematic Review and Meta-Analysis. Hellenic J Cardiol. 2024;79:58-69. doi: 10.1016/j.hjc.2023.09.010.</mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Voigt</surname><given-names>JU</given-names></name>
<name><surname>Pedrizzetti</surname><given-names>G</given-names></name>
<name><surname>Lysyansky</surname><given-names>P</given-names></name>
<name><surname>Marwick</surname><given-names>TH</given-names></name>
<name><surname>Houle</surname><given-names>H</given-names></name>
<name><surname>Baumann</surname><given-names>R</given-names></name>
<etal/>
</person-group>
<article-title>Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging</article-title>
<source>J Am Soc Echocardiogr</source>
<year>2015</year>
<volume>28</volume>
<issue>2</issue>
<fpage>183</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1016/j.echo.2014.11.003</pub-id>
</element-citation>
<mixed-citation>Voigt JU, Pedrizzetti G, Lysyansky P, Marwick TH, Houle H, Baumann R, et al. Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging. J Am Soc Echocardiogr. 2015;28(2):183-93. doi: 10.1016/j.echo.2014.11.003.</mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Shinzato</surname><given-names>MH</given-names></name>
<name><surname>Santos</surname><given-names>N</given-names></name>
<name><surname>Nishida</surname><given-names>G</given-names></name>
<name><surname>Moriya</surname><given-names>H</given-names></name>
<name><surname>Assef</surname><given-names>J</given-names></name>
<name><surname>Feres</surname><given-names>F</given-names></name>
<etal/>
</person-group>
<article-title>Left Ventricular and Atrial Myocardial Strain in Heart Failure with Preserved Ejection Fraction: The Evidence so far and Prospects for Phenotyping Strategy</article-title>
<source>Cardiovasc Ultrasound</source>
<year>2024</year>
<volume>22</volume>
<issue>1</issue>
<fpage>4</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1186/s12947-024-00323-1</pub-id>
</element-citation>
<mixed-citation>Shinzato MH, Santos N, Nishida G, Moriya H, Assef J, Feres F, et al. Left Ventricular and Atrial Myocardial Strain in Heart Failure with Preserved Ejection Fraction: The Evidence so far and Prospects for Phenotyping Strategy. Cardiovasc Ultrasound. 2024;22(1):4. doi: 10.1186/s12947-024-00323-1.</mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Pieske</surname><given-names>B</given-names></name>
<name><surname>Tschöpe</surname><given-names>C</given-names></name>
<name><surname>Boer</surname><given-names>RA</given-names></name>
<name><surname>Fraser</surname><given-names>AG</given-names></name>
<name><surname>Anker</surname><given-names>SD</given-names></name>
<name><surname>Donal</surname><given-names>E</given-names></name>
<etal/>
</person-group>
<article-title>How to Diagnose Heart Failure with Preserved Ejection Fraction: The HFA-PEFF Diagnostic Algorithm: A Consensus Recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)</article-title>
<source>Eur Heart J</source>
<year>2019</year>
<volume>40</volume>
<issue>40</issue>
<fpage>3297</fpage>
<lpage>3317</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehz641</pub-id>
</element-citation>
<mixed-citation>Pieske B, Tschöpe C, Boer RA, Fraser AG, Anker SD, Donal E, et al. How to Diagnose Heart Failure with Preserved Ejection Fraction: The HFA-PEFF Diagnostic Algorithm: A Consensus Recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297-317. doi: 10.1093/eurheartj/ehz641.</mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Heidenreich</surname><given-names>PA</given-names></name>
<name><surname>Bozkurt</surname><given-names>B</given-names></name>
<name><surname>Aguilar</surname><given-names>D</given-names></name>
<name><surname>Allen</surname><given-names>LA</given-names></name>
<name><surname>Byun</surname><given-names>JJ</given-names></name>
<name><surname>Colvin</surname><given-names>MM</given-names></name>
<etal/>
</person-group>
<article-title>2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</article-title>
<source>Circulation</source>
<year>2022</year>
<volume>145</volume>
<issue>18</issue>
<fpage>876</fpage>
<lpage>894</lpage>
<pub-id pub-id-type="doi">10.1161/CIR.0000000000001062</pub-id>
</element-citation>
<mixed-citation>Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):876-94. doi: 10.1161/CIR.0000000000001062.</mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Tan</surname><given-names>TS</given-names></name>
<name><surname>Serifler</surname><given-names>NT</given-names></name>
<name><surname>Demirtola</surname><given-names>AI</given-names></name>
<name><surname>Akbulut</surname><given-names>IM</given-names></name>
<name><surname>Ozyuncu</surname><given-names>N</given-names></name>
<name><surname>Vurgun</surname><given-names>VK</given-names></name>
<etal/>
</person-group>
<article-title>Invasive Validation of the Left Ventricular Global Longitudinal Strain for Estimating Left Ventricular Filling Pressure</article-title>
<source>Echocardiography</source>
<year>2021</year>
<volume>38</volume>
<issue>7</issue>
<fpage>1133</fpage>
<lpage>1140</lpage>
<pub-id pub-id-type="doi">10.1111/echo.15127</pub-id>
</element-citation>
<mixed-citation>Tan TS, Serifler NT, Demirtola AI, Akbulut IM, Ozyuncu N, Vurgun VK, et al. Invasive Validation of the Left Ventricular Global Longitudinal Strain for Estimating Left Ventricular Filling Pressure. Echocardiography. 2021;38(7):1133-40. doi: 10.1111/echo.15127.</mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Miranda</surname><given-names>WR</given-names></name>
<name><surname>Borlaug</surname><given-names>BA</given-names></name>
<name><surname>Jain</surname><given-names>CC</given-names></name>
<name><surname>Anderson</surname><given-names>JH</given-names></name>
<name><surname>Hagler</surname><given-names>DJ</given-names></name>
<name><surname>Connolly</surname><given-names>HM</given-names></name>
<etal/>
</person-group>
<article-title>Exercise-induced Changes in Pulmonary Artery Wedge Pressure in Adults Post-Fontan versus Heart Failure with Preserved Ejection Fraction and Non-cardiac Dyspnoea</article-title>
<source>Eur J Heart Fail</source>
<year>2023</year>
<volume>25</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1002/ejhf.2706</pub-id>
</element-citation>
<mixed-citation>Miranda WR, Borlaug BA, Jain CC, Anderson JH, Hagler DJ, Connolly HM, et al. Exercise-induced Changes in Pulmonary Artery Wedge Pressure in Adults Post-Fontan versus Heart Failure with Preserved Ejection Fraction and Non-cardiac Dyspnoea. Eur J Heart Fail. 2023;25(1):17-25. doi: 10.1002/ejhf.2706.</mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Borlaug</surname><given-names>BA</given-names></name>
<name><surname>Nishimura</surname><given-names>RA</given-names></name>
<name><surname>Sorajja</surname><given-names>P</given-names></name>
<name><surname>Lam</surname><given-names>CS</given-names></name>
<name><surname>Redfield</surname><given-names>MM</given-names></name>
</person-group>
<article-title>Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure with Preserved Ejection Fraction</article-title>
<source>Circ Heart Fail</source>
<year>2010</year>
<volume>3</volume>
<issue>5</issue>
<fpage>588</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.109.930701</pub-id>
</element-citation>
<mixed-citation>Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM. Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure with Preserved Ejection Fraction. Circ Heart Fail. 2010;3(5):588-95. doi: 10.1161/CIRCHEARTFAILURE.109.930701.</mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Oh</surname><given-names>JK</given-names></name>
<name><surname>Miranda</surname><given-names>WR</given-names></name>
<name><surname>Kane</surname><given-names>GC</given-names></name>
</person-group>
<article-title>Diagnosis of Heart Failure with Preserved Ejection Fraction Relies on Detection of Increased Diastolic Filling Pressure, But How?</article-title>
<source>J Am Heart Assoc</source>
<year>2023</year>
<volume>12</volume>
<issue>6</issue>
<comment>e028867</comment>
<pub-id pub-id-type="doi">10.1161/JAHA.122.028867</pub-id>
</element-citation>
<mixed-citation>Oh JK, Miranda WR, Kane GC. Diagnosis of Heart Failure with Preserved Ejection Fraction Relies on Detection of Increased Diastolic Filling Pressure, But How? J Am Heart Assoc. 2023;12(6):e028867. doi: 10.1161/JAHA.122.028867.</mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Davidavicius</surname><given-names>G</given-names></name>
<name><surname>Kowalski</surname><given-names>M</given-names></name>
<name><surname>Williams</surname><given-names>RI</given-names></name>
<name><surname>D&apos;hooge</surname><given-names>J</given-names></name>
<name><surname>Di Salvo</surname><given-names>G</given-names></name>
<name><surname>Pierre-Justin</surname><given-names>G</given-names></name>
<etal/>
</person-group>
<article-title>Can Regional Strain and Strain Rate Measurement be Performed During Both Dobutamine and Exercise Echocardiography, and do Regional Deformation Responses Differ with Different Forms of Stress Testing?</article-title>
<source>J Am Soc Echocardiogr</source>
<year>2003</year>
<volume>16</volume>
<issue>4</issue>
<fpage>299</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1016/s0894-7317(02)74428-3</pub-id>
</element-citation>
<mixed-citation>Davidavicius G, Kowalski M, Williams RI, D&apos;hooge J, Di Salvo G, Pierre-Justin G, et al. Can Regional Strain and Strain Rate Measurement be Performed During Both Dobutamine and Exercise Echocardiography, and do Regional Deformation Responses Differ with Different Forms of Stress Testing? J Am Soc Echocardiogr. 2003;16(4):299-308. doi: 10.1016/s0894-7317(02)74428-3.</mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Poliner</surname><given-names>LR</given-names></name>
<name><surname>Dehmer</surname><given-names>GJ</given-names></name>
<name><surname>Lewis</surname><given-names>SE</given-names></name>
<name><surname>Parkey</surname><given-names>RW</given-names></name>
<name><surname>Blomqvist</surname><given-names>CG</given-names></name>
<name><surname>Willerson</surname><given-names>JT</given-names></name>
</person-group>
<article-title>Left Ventricular Performance in Normal Subjects: A Comparison of the Responses to Exercise in the Upright and Supine Positions</article-title>
<source>Circulation</source>
<year>1980</year>
<volume>62</volume>
<issue>3</issue>
<fpage>528</fpage>
<lpage>534</lpage>
<pub-id pub-id-type="doi">10.1161/01.cir.62.3.528</pub-id>
</element-citation>
<mixed-citation>Poliner LR, Dehmer GJ, Lewis SE, Parkey RW, Blomqvist CG, Willerson JT. Left Ventricular Performance in Normal Subjects: A Comparison of the Responses to Exercise in the Upright and Supine Positions. Circulation. 1980;62(3):528-34. doi: 10.1161/01.cir.62.3.528.</mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="book">
<person-group person-group-type="editor">
<name><surname>Loizou</surname><given-names>CP</given-names></name>
<name><surname>Pattichis</surname><given-names>CS</given-names></name>
<name><surname>D&apos;Hooge</surname><given-names>J</given-names></name>
</person-group>
<chapter-title>Handbook of Speckle Filtering and Tracking in Cardiovascular Ultrasound Imaging and Video</chapter-title>
<source>Hertfordshire: Institution of Engineering and Technology</source>
<year>2018</year>
</element-citation>
<mixed-citation>Loizou CP, Pattichis CS, D&apos;Hooge J, editor. Handbook of Speckle Filtering and Tracking in Cardiovascular Ultrasound Imaging and Video. Hertfordshire: Institution of Engineering and Technology; 2018.</mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Sousa</surname><given-names>RD</given-names></name>
<name><surname>Regis</surname><given-names>CDM</given-names></name>
<name><surname>Silva</surname><given-names>IDS</given-names></name>
<name><surname>Szewierenko</surname><given-names>P</given-names></name>
<name><surname>Hortegal</surname><given-names>RA</given-names></name>
<name><surname>Abensur</surname><given-names>H</given-names></name>
</person-group>
<article-title>Software for Post-processing Analysis of Strain Curves: The D-Station</article-title>
<source>Arq Bras Cardiol</source>
<year>2020</year>
<volume>114</volume>
<issue>3</issue>
<fpage>496</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.36660/abc.20180403</pub-id>
</element-citation>
<mixed-citation>Sousa RD, Regis CDM, Silva IDS, Szewierenko P, Hortegal RA, Abensur H. Software for Post-processing Analysis of Strain Curves: The D-Station. Arq Bras Cardiol. 2020;114(3):496-506. doi: 10.36660/abc.20180403.</mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Blum</surname><given-names>M</given-names></name>
<name><surname>Hashemi</surname><given-names>D</given-names></name>
<name><surname>Motzkus</surname><given-names>LA</given-names></name>
<name><surname>Neye</surname><given-names>M</given-names></name>
<name><surname>Dordevic</surname><given-names>A</given-names></name>
<name><surname>Zieschang</surname><given-names>V</given-names></name>
<etal/>
</person-group>
<article-title>Variability of Myocardial Strain During Isometric Exercise in Subjects with and Without Heart Failure</article-title>
<source>Front Cardiovasc Med</source>
<year>2020</year>
<volume>7</volume>
<fpage>111</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.3389/fcvm.2020.00111</pub-id>
</element-citation>
<mixed-citation>Blum M, Hashemi D, Motzkus LA, Neye M, Dordevic A, Zieschang V, et al. Variability of Myocardial Strain During Isometric Exercise in Subjects with and Without Heart Failure. Front Cardiovasc Med. 2020;7:111. doi: 10.3389/fcvm.2020.00111.</mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Murai</surname><given-names>D</given-names></name>
<name><surname>Yamada</surname><given-names>S</given-names></name>
<name><surname>Hayashi</surname><given-names>T</given-names></name>
<name><surname>Okada</surname><given-names>K</given-names></name>
<name><surname>Nishino</surname><given-names>H</given-names></name>
<name><surname>Nakabachi</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Relationships of Left Ventricular Strain and Strain Rate to Wall Stress and their Afterload Dependency</article-title>
<source>Heart Vessels</source>
<year>2017</year>
<volume>32</volume>
<issue>5</issue>
<fpage>574</fpage>
<lpage>583</lpage>
<pub-id pub-id-type="doi">10.1007/s00380-016-0900-4</pub-id>
</element-citation>
<mixed-citation>Murai D, Yamada S, Hayashi T, Okada K, Nishino H, Nakabachi M, et al. Relationships of Left Ventricular Strain and Strain Rate to Wall Stress and their Afterload Dependency. Heart Vessels. 2017;32(5):574-83. doi: 10.1007/s00380-016-0900-4.</mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Weiner</surname><given-names>RB</given-names></name>
<name><surname>Weyman</surname><given-names>AE</given-names></name>
<name><surname>Kim</surname><given-names>JH</given-names></name>
<name><surname>Wang</surname><given-names>TJ</given-names></name>
<name><surname>Picard</surname><given-names>MH</given-names></name>
<name><surname>Baggish</surname><given-names>AL</given-names></name>
</person-group>
<article-title>The Impact of Isometric Handgrip Testing on Left Ventricular Twist Mechanics</article-title>
<source>J Physiol</source>
<year>2012</year>
<volume>590</volume>
<issue>20</issue>
<fpage>5141</fpage>
<lpage>5150</lpage>
<pub-id pub-id-type="doi">10.1113/jphysiol.2012.236166</pub-id>
</element-citation>
<mixed-citation>Weiner RB, Weyman AE, Kim JH, Wang TJ, Picard MH, Baggish AL. The Impact of Isometric Handgrip Testing on Left Ventricular Twist Mechanics. J Physiol. 2012;590(20):5141-50. doi: 10.1113/jphysiol.2012.236166.</mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Hortegal</surname><given-names>RA</given-names></name>
<name><surname>Hossri</surname><given-names>C</given-names></name>
<name><surname>Giolo</surname><given-names>L</given-names></name>
<name><surname>Cancellier</surname><given-names>R</given-names></name>
<name><surname>Gun</surname><given-names>C</given-names></name>
<name><surname>Assef</surname><given-names>J</given-names></name>
<etal/>
</person-group>
<article-title>Mechanical Dispersion is a Superior Echocardiographic Feature to Predict Exercise Capacity in Preclinical and Overt Heart Failure with Preserved Ejection Fraction</article-title>
<source>Int J Cardiovasc Imaging</source>
<year>2023</year>
<volume>39</volume>
<issue>7</issue>
<fpage>1239</fpage>
<lpage>1250</lpage>
<pub-id pub-id-type="doi">10.1007/s10554-023-02830-0</pub-id>
</element-citation>
<mixed-citation>Hortegal RA, Hossri C, Giolo L, Cancellier R, Gun C, Assef J, et al. Mechanical Dispersion is a Superior Echocardiographic Feature to Predict Exercise Capacity in Preclinical and Overt Heart Failure with Preserved Ejection Fraction. Int J Cardiovasc Imaging. 2023;39(7):1239-50. doi: 10.1007/s10554-023-02830-0.</mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Aalen</surname><given-names>J</given-names></name>
<name><surname>Storsten</surname><given-names>P</given-names></name>
<name><surname>Remme</surname><given-names>EW</given-names></name>
<name><surname>Sirnes</surname><given-names>PA</given-names></name>
<name><surname>Gjesdal</surname><given-names>O</given-names></name>
<name><surname>Larsen</surname><given-names>CK</given-names></name>
<etal/>
</person-group>
<article-title>Afterload Hypersensitivity in Patients with Left Bundle Branch Block</article-title>
<source>JACC Cardiovasc Imaging</source>
<year>2019</year>
<volume>12</volume>
<issue>6</issue>
<fpage>967</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcmg.2017.11.025</pub-id>
</element-citation>
<mixed-citation>Aalen J, Storsten P, Remme EW, Sirnes PA, Gjesdal O, Larsen CK, et al. Afterload Hypersensitivity in Patients with Left Bundle Branch Block. JACC Cardiovasc Imaging. 2019;12(6):967-77. doi: 10.1016/j.jcmg.2017.11.025.</mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Ishigaki</surname><given-names>T</given-names></name>
<name><surname>Asanuma</surname><given-names>T</given-names></name>
<name><surname>Yagi</surname><given-names>N</given-names></name>
<name><surname>Izumi</surname><given-names>H</given-names></name>
<name><surname>Shimizu</surname><given-names>S</given-names></name>
<name><surname>Fujisawa</surname><given-names>Y</given-names></name>
<etal/>
</person-group>
<article-title>Incremental Value of Early Systolic Lengthening and Postsystolic Shortening in Detecting Left Anterior Descending Artery Stenosis Using Nonstress Speckle-tracking Echocardiography</article-title>
<source>Sci Rep</source>
<year>2021</year>
<volume>11</volume>
<issue>1</issue>
<fpage>19359</fpage>
<lpage>19359</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-021-98900-1</pub-id>
</element-citation>
<mixed-citation>Ishigaki T, Asanuma T, Yagi N, Izumi H, Shimizu S, Fujisawa Y, et al. Incremental Value of Early Systolic Lengthening and Postsystolic Shortening in Detecting Left Anterior Descending Artery Stenosis Using Nonstress Speckle-tracking Echocardiography. Sci Rep. 2021;11(1):19359. doi: 10.1038/s41598-021-98900-1.</mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>De Sutter</surname><given-names>J</given-names></name>
<name><surname>Van de Veire</surname><given-names>NR</given-names></name>
<name><surname>Muyldermans</surname><given-names>L</given-names></name>
<name><surname>De Backer</surname><given-names>T</given-names></name>
<name><surname>Hoffer</surname><given-names>E</given-names></name>
<name><surname>Vaerenberg</surname><given-names>M</given-names></name>
<etal/>
</person-group>
<article-title>Prevalence of Mechanical Dyssynchrony in Patients with Heart Failure and Preserved Left Ventricular Function (A Report from the Belgian Multicenter Registry on Dyssynchrony)</article-title>
<source>Am J Cardiol</source>
<year>2005</year>
<volume>96</volume>
<issue>11</issue>
<fpage>1543</fpage>
<lpage>1548</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjcard.2005.07.062</pub-id>
</element-citation>
<mixed-citation>De Sutter J, Van de Veire NR, Muyldermans L, De Backer T, Hoffer E, Vaerenberg M, et al. Prevalence of Mechanical Dyssynchrony in Patients with Heart Failure and Preserved Left Ventricular Function (A Report from the Belgian Multicenter Registry on Dyssynchrony). Am J Cardiol. 2005;96(11):1543-8. doi: 10.1016/j.amjcard.2005.07.062.</mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Morris</surname><given-names>DA</given-names></name>
<name><surname>Pérez</surname><given-names>AV</given-names></name>
<name><surname>Blaschke</surname><given-names>F</given-names></name>
<name><surname>Eichstädt</surname><given-names>H</given-names></name>
<name><surname>Ozcelik</surname><given-names>C</given-names></name>
<name><surname>Haverkamp</surname><given-names>W</given-names></name>
</person-group>
<article-title>Myocardial Systolic and Diastolic Consequences of Left Ventricular Mechanical Dyssynchrony in Heart Failure with Normal Left Ventricular Ejection Fraction</article-title>
<source>Eur Heart J Cardiovasc Imaging</source>
<year>2012</year>
<volume>13</volume>
<issue>7</issue>
<fpage>556</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="doi">10.1093/ehjci/jes042</pub-id>
</element-citation>
<mixed-citation>Morris DA, Pérez AV, Blaschke F, Eichstädt H, Ozcelik C, Haverkamp W. Myocardial Systolic and Diastolic Consequences of Left Ventricular Mechanical Dyssynchrony in Heart Failure with Normal Left Ventricular Ejection Fraction. Eur Heart J Cardiovasc Imaging. 2012;13(7):556-67. doi: 10.1093/ehjci/jes042.</mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Argulian</surname><given-names>E</given-names></name>
<name><surname>Chandrashekhar</surname><given-names>Y</given-names></name>
<name><surname>Shah</surname><given-names>SJ</given-names></name>
<name><surname>Huttin</surname><given-names>O</given-names></name>
<name><surname>Pitt</surname><given-names>B</given-names></name>
<name><surname>Zannad</surname><given-names>F</given-names></name>
<etal/>
</person-group>
<article-title>Teasing Apart Heart Failure with Preserved Ejection Fraction Phenotypes with Echocardiographic Imaging: Potential Approach to Research and Clinical Practice</article-title>
<source>Circ Res</source>
<year>2018</year>
<volume>122</volume>
<issue>1</issue>
<fpage>23</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.312180</pub-id>
</element-citation>
<mixed-citation>Argulian E, Chandrashekhar Y, Shah SJ, Huttin O, Pitt B, Zannad F, et al. Teasing Apart Heart Failure with Preserved Ejection Fraction Phenotypes with Echocardiographic Imaging: Potential Approach to Research and Clinical Practice. Circ Res. 2018;122(1):23-5. doi: 10.1161/CIRCRESAHA.117.312180.</mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name><surname>Donal</surname><given-names>E</given-names></name>
<name><surname>Behagel</surname><given-names>A</given-names></name>
<name><surname>Feneon</surname><given-names>D</given-names></name>
</person-group>
<article-title>Value of Left Atrial Strain: A Highly Promising Field of Investigation</article-title>
<source>Eur Heart J Cardiovasc Imaging</source>
<year>2015</year>
<volume>16</volume>
<issue>4</issue>
<fpage>356</fpage>
<lpage>357</lpage>
<pub-id pub-id-type="doi">10.1093/ehjci/jeu230</pub-id>
</element-citation>
<mixed-citation>Donal E, Behagel A, Feneon D. Value of Left Atrial Strain: A Highly Promising Field of Investigation. Eur Heart J Cardiovasc Imaging. 2015;16(4):356-7. doi: 10.1093/ehjci/jeu230.</mixed-citation>
</ref>
</ref-list>
</back>
<sub-article article-type="translation" id="S1" xml:lang="pt">
<front-stub>
<article-id pub-id-type="doi">10.36660/abcimg.20240104</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Artigo de Revisão</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Strain do Ventrículo Esquerdo na ICFEp: Uma Visão Prática dos Aspectos Diagnósticos, Resposta ao Exercício e ao Desafio de Pós-carga</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0003-0031-335X</contrib-id>
<name><surname>Hortegal</surname> <given-names>Renato A.</given-names></name>
<role>Concepção e desenho da pesquisa</role>
<role>obtenção de dados</role>
<role>redação do manuscrito</role>
<xref ref-type="aff" rid="aff4"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">0000-0002-1919-164X</contrib-id>
<name><surname>Bihan</surname> <given-names>David Le</given-names></name>
<role>Concepção e desenho da pesquisa</role>
<role>obtenção de dados</role>
<role>redação do manuscrito</role>
<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
<xref ref-type="aff" rid="aff4"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c2"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mathias</surname> <given-names>Mariana Mendes</given-names></name>
<role>Concepção e desenho da pesquisa</role>
<role>redação do manuscrito</role>
<xref ref-type="aff" rid="aff6"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">0000-0002-0890-5870</contrib-id>
<name><surname>Barretto</surname> <given-names>Rodrigo</given-names></name>
<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
<xref ref-type="aff" rid="aff4"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Mathias</surname> <given-names>Wilson</given-names><suffix>Jr</suffix></name>
<role>revisão crítica do manuscrito quanto ao conteúdo intelectual importante</role>
<xref ref-type="aff" rid="aff4"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>2</sup></xref>
</contrib>
<aff id="aff4">
<label>1</label>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">Universidade de São Paulo, Instituto do Coração, São Paulo, SP - Brasil</institution>
</aff>
<aff id="aff5">
<label>2</label>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">Grupo Fleury, São Paulo, SP - Brasil</institution>
</aff>
<aff id="aff6">
<label>3</label>
<addr-line>
<named-content content-type="city">São Paulo</named-content>
<named-content content-type="state">SP</named-content>
</addr-line>
<country country="BR">Brasil</country>
<institution content-type="original">Hospital das Clínicas FMUSP, São Paulo, SP - Brasil</institution>
</aff>
</contrib-group>
<author-notes>
<corresp id="c2"><label>Correspondência:</label> <bold>David Le Bihan</bold> • Instituto do Coração (InCor), Hospital das Clínicas da Faculdade de Medicina da USP. Av. Dr. Enéas Carvalho de Aguiar, 44. CEP: <postal-code>05403-900</postal-code>. Cerqueira César, Sao Paulo, SP - Brasil E-mail: <email>david.bihan@hc.fm.usp.br</email></corresp>
<fn fn-type="conflict"><label>Potencial Conflito de Interesse</label> <p>Declaro não haver conflito de interesses pertinentes.</p></fn>
<fn fn-type="edited-by"><label>Editor responsável pela revisão:</label> <p>Marcelo Tavares</p></fn>
</author-notes>
<abstract>
<title>Resumo</title>
<p>A Insuficiência Cardíaca com Fração de Ejeção Preservada (ICFEp) é um desafio crescente na cardiologia, marcada por anormalidades na função sistólica e/ou diastólica. Pacientes com ICFEp frequentemente apresentam intolerância ao exercício, mas o diagnóstico é muitas vezes dificultado devido sobreposição de comorbidades, como obesidade e hipertensão. A Deformação Longitudinal Global (GLS) do ventrículo esquerdo (VE) permite a detecção de disfunções sistólicas sutis, em que estudos apontam uma correlação mais forte entre o GLS e a capacidade de realização do exercício do que a fração de ejeção (FE). Na ecocardiografia de exercício, o GLS exibe um padrão bimodal característico devido a adaptações hemodinâmicas, com desvios sugerindo ICFEp. Em caso de inviabilidade do teste de exercício ou quando a avaliação específica do acoplamento ventricular-arterial é desejada, um desafio de pós-carga oferece uma alternativa controlada ao aumentar a resistência sistêmica. Além do GLS, a dispersão mecânica (MD) mede a heterogeneidade contrátil, enquanto a deformação atrial esquerda (StrainAE) se mostrou promissora na identificação de disfunção atrial ligada à ICFEp. Esses parâmetros, avaliados juntamente com as razões E/e&apos; e a pressão sistólica pulmonar durante o exercício, melhoram o diagnóstico de ICFEp, oferecem uma visão mais abrangente da fisiopatologia da síndrome e garantem informações valiosas para fundamentar a decisão de tratamento.</p>
</abstract>
<kwd-group xml:lang="pt">
<title>Palavras-chave</title>
<kwd>Insuficiência Cardíaca</kwd>
<kwd>Ecocardiografia</kwd>
<kwd>Exercício Físico</kwd>
</kwd-group>
</front-stub>
<body>
<sec sec-type="intro">
<title>Introdução</title>
<p>A insuficiência cardíaca com fração de ejeção preservada (ICFEp) é uma doença prioritária em saúde pública, contabilizando pelo menos 50% de todos os pacientes com insuficiência cardíaca, e com uma prevalência crescente.<sup><xref ref-type="bibr" rid="B1">1</xref></sup> Essa condição representa uma grande necessidade não atendida em cardiologia, e com lacunas consideráveis de conhecimento sobre sua fisiopatologia, história natural, diagnóstico e tratamento.<sup><xref ref-type="bibr" rid="B1">1</xref></sup></p>
<p>A principal queixa dos pacientes com ICFEp é a intolerância ao exercício. No entanto, avaliar esse sintoma com precisão, com base apenas na anamnese, pode ser um desafio. O fenótipo típico de ICFEp, frequentemente chamado de ICFEp "Garden Variety" (um termo em inglês que descreve algo comum ou padrão, sem características excepcionais), habitualmente inclui pelo menos quatro comorbidades, como obesidade, hipertensão, fibrilação atrial e doença renal. Essas comorbidades complicam o diagnóstico diferencial, dificultando a distinção entre a capacidade reduzida de exercício causada pelas comorbidades e a síndrome de insuficiência cardíaca propriamente dita.<sup><xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref></sup> Além disso, muitos pacientes têm apresentações clínicas sem sinais de hipervolemia ao exame físico, limitando a sensibilidade dos critérios dos clássicos de Framinghan.<sup><xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref></sup></p>
<p>Nesse contexto, a ecocardiografia desempenha um papel crucial na avaliação de pacientes com suspeita de ICFEp, e a imagem da deformação pode, de fato, oferecer informações críticas para melhorar o desempenho diagnóstico.<sup><xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref></sup> A ICFEp tem sido tradicionalmente associada à disfunção diastólica grave, levando à "insuficiência cardíaca retrógrada" e congestão pulmonar, o que limita a capacidade de exercício.<sup><xref ref-type="bibr" rid="B7">7</xref></sup></p>
<p>Embora a disfunção diastólica seja inegavelmente fundamental na fisiopatologia da ICFEp, outras anormalidades, incluindo disfunção sistólica sutil, apesar da fração de ejeção (FE) preservada, também desempenham um papel importante.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref></sup> O uso da Deformação Longitudinal Global (GLS) do ventrículo esquerdo (VE) nos permite avaliar tais anormalidades da função sistólica.<sup><xref ref-type="bibr" rid="B2">2</xref></sup></p>
<sec>
<title>GLS do VE como um critério diagnóstico para ICFEp</title>
<p>Os requisitos técnicos para obter um GLS de alta qualidade foram detalhados nas diretrizes.<sup><xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup> A faixa normal de GLS é entre 18% e 22% (valores modulares), com valores entre 16% e 18% considerados limítrofes. Valores de GLS abaixo de 16% são indicativos de disfunção sistólica.<sup><xref ref-type="bibr" rid="B11">11</xref></sup></p>
<p>O escore proposto pela Sociedade Europeia de Cardiologia (HFA-PEFF)<sup><xref ref-type="bibr" rid="B12">12</xref></sup> inclui o GLS como uma característica no domínio funcional, juntamente com outras métricas dos domínios estrutural (domínio morfológico) e de biomarcadores (peptídeos natriuréticos) (<xref ref-type="fig" rid="f6">Figura 1</xref>). Essa abordagem é importante, pois orienta o médico a interpretar o GLS no contexto dessas outras características para o diagnóstico da ICFEp.</p>
<fig id="f6">
<label>Figura 1</label>
<caption><title>O escore HFA-PEFF para o diagnóstico de ICFEp. Escore HFA-PEFF para avaliar o diagnóstico de ICFEp. HFA-PEFF: PEFF da Heart Failure Association; NP: peptídeo natriurético; e&apos;: velocidade anular mitral diastólica precoce; E: velocidade de fluxo transmitral precoce; VRT: velocidade de regurgitação tricúspide; GLS: deformação longitudinal global do ventrículo esquerdo; IVAE: índice de volume atrial esquerdo; IMVE: índice de massa ventricular esquerda; ERP: espessura relativa da parede; VE: ventrículo esquerdo; RS: ritmo sinusal; NT-pro-BNP: N-terminal pró-peptídeo natriurético tipo B; BNP: peptídeo natriurético tipo B; FA: fibrilação atrial; ICFEp: Insuficiência Cardíaca com Fração de Ejeção Preservada; TR: refluxo tricúspide. *Os valores devem ser ajustados para e&apos;&lt;5cm/s e e&apos; lateral&lt;7cm/s se o paciente tiver idade&gt;75 anos/s.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-pt-gf01.tif"/>
</fig>
<p>Avaliar o GLS em conjunto com outras características é fundamental, pois um GLS anormal tem sido associado a diversas condições clínicas conhecidas por prejudicar o miocárdio, como hipertensão, diabetes mellitus, estenose aórtica e amiloidose. Essas condições podem atuar como fatores de risco ou mimetizadores de ICFEp.<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B13">13</xref></sup></p>
<p>Anormalidades no GLS, sem outros comprometimentos fisiopatológicos, podem não preencher todas as condições para aumentar as pressões de enchimento e causar a síndrome ICFEp. De fato, há evidências de que o GLS tem uma correlação apenas moderada com a pressão de enchimento do ventrículo esquerdo.<sup><xref ref-type="bibr" rid="B14">14</xref></sup> Em contrapartida, outros estudos apontam que a ICFEp franca pode ocorrer sem alterações significativas no GLS em repouso, indicando que o uso isolado deste índice tem uma sensibilidade limitada..<sup><xref ref-type="bibr" rid="B11">11</xref></sup></p>
<p>No entanto, existem evidências de que o GLS pode ter um papel significativo nas adaptações fisiológicas cardiocirculatórias que determinam a capacidade de exercício. Uma meta-análise recente de 25 estudos, compreendendo 2136 pacientes com FE preservada e reduzida, demonstrou que tanto o GLS quanto o FE têm uma relação linear com o pico de consumo de oxigênio (VO<sub>2</sub>). No entanto, a correlação entre VO<sub>2</sub> e GLS foi duas vezes mais forte que a correlação entre VO<sub>2</sub> e FE.<sup><xref ref-type="bibr" rid="B9">9</xref></sup> Essas descobertas destacam a relevância dos recursos de imagem de deformação na avaliação dos componentes cardiocirculatórios da intolerância ao exercício.</p>
</sec>
<sec>
<title>GLS do VE na ecocardiografia de exercício</title>
<p>Pacientes com ICFEP podem apresentar anormalidades funcionais, especialmente durante a sobrecarga hemodinâmica. O teste de exercício utilizando um cicloergômetro é a modalidade de escolha para induzir tal estresse.<sup><xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref></sup> Avaliar o GLS durante o exercício é, portanto, lógico e tem potencial significativo para aumentar a precisão precisão diagnóstica em ICFEP.</p>
<p>Reconhecer que o GLS é um parâmetro sensível à carga<sup><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B10">10</xref></sup> é essencial, e seu comportamento durante o exercício deve ser interpretado no contexto das adaptações fisiológicas que ocorrem em diferentes fases do esforço. No estágio inicial do exercício, o débito cardíaco aumenta em função dos incrementos de pré-carga e da contratilidade cardíaca, resultando em um maior volume sistólico. Nesta fase, o GLS normalmente aumenta em comparação às condições de repouso. Na fase subsequente, aproximadamente após o primeiro limiar ventilatório, o volume sistólico tende a estabilizar, e o incremento adicional no débito cardíaco ocorre pelo aumento da frequência cardíaca, o que reduz a pré-carga e, consequentemente, diminui o GLS.<sup><xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref></sup> Assim, o GLS demonstra um padrão bimodal característico durante o exercício (<xref ref-type="fig" rid="f7">Figura 2</xref>).</p>
<fig id="f7">
<label>Figura 2</label>
<caption><title>Comportamento bimodal do GLS durante o exercício. GLS: Deformação longitudinal global; LAV: Limiar anaeróbico ventilatório.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-pt-gf02.tif"/>
</fig>
<p>Apesar disso, há uma lacuna evidente na pesquisa sobre como desvios patológicos na ICFEp podem afetar ou alterar os padrões do GLS durante o exercício.</p>
</sec>
<sec>
<title>Compensação entre taxa de quadros e frequência cardíaca durante o exercício</title>
<p>Uma das principais considerações técnicas ao avaliar o GLS durante a ecocardiografia de exercício é a compensação entre a taxa de quadros (fps) e a frequência cardíaca. À medida que a frequência cardíaca aumenta durante o exercício, o ciclo cardíaco encurta, exigindo uma taxa de quadros mais alta para capturar detalhes do movimento do miocárdio ao longo do ciclo. Capturar a deformação do miocárdio com precisão, especialmente durante frequências cardíacas elevadas, é um desafio técnico significativo.<sup><xref ref-type="bibr" rid="B20">20</xref></sup></p>
<p>Taxas de quadros mais altas são necessárias para alcançar boa resolução temporal, mas isso frequentemente ocorre às custas da resolução espacial, o que pode comprometer a precisão das medições de deformação.<sup><xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref></sup></p>
<p>Otimizar a taxa de quadros durante a ecocardiografia de exercício é essencial para equilibrar a necessidade de resolução temporal detalhada e as limitações da resolução espacial. Uma taxa de quadros inadequada pode levar à subamostragem do movimento do miocárdio, resultando em medições imprecisas do GLS e potencial interpretação errônea da função miocárdica.<sup><xref ref-type="bibr" rid="B20">20</xref></sup></p>
<p>Na prática clínica, é essencial ajustar as configurações de ultrassom dinamicamente durante o exercício para manter as taxas de quadros ideais conforme as frequências cardíacas aumentam. Esse ajuste dinâmico ajuda a garantir que as medições de GLS permaneçam confiáveis e reflitam o verdadeiro desempenho do miocárdio sob condições de exercício. Para uma avaliação precisa do pico de deformação longitudinal e circunferencial de pico, recomenda-se uma proporção de 30 quadros por ciclo cardíaco. Isso significa que a taxa de quadros mínima deve ser ajustada para garantir que pelo menos 30 quadros sejam capturados durante cada ciclo cardíaco para garantir medições de deformação confiáveis. Por exemplo, para uma frequência cardíaca de 80 bpm, a taxa de quadros mínima seria &gt; 40 fps, enquanto para uma frequência cardíaca de 160 bpm, a taxa de quadros mínima seria &gt; 85 fps. Do ponto de vista prático, deve-se buscar manter uma taxa de quadros acima de 70% da frequência cardíaca. Vale ressaltar que isso não se aplica à avaliação das fases isovolumétricas, em que taxas de quadros tão altas quanto 500 fps seriam necessárias, sendo uma área ainda a ser explorada com os novos algoritmos de <italic>speckle tracking</italic> com alta resolução temporal.</p>
</sec>
<sec>
<title>GLS do VE no desafio de pós-carga</title>
<p>Em determinados cenários clínicos ou devido a limitações técnicas, a realização dos protocolos convencionais de exercício pode não ser viável. Nesses casos, modalidades alternativas de estresse, como desafio de pré ou pós-carga, podem fornecer informações valiosas sobre a função miocárdica.<sup><xref ref-type="bibr" rid="B2">2</xref></sup> Um desafio de pós-carga consiste em induzir sobrecarga de pressão para avaliar o desempenho miocárdico em condições de resistência sistêmica aumentada. Isso pode ser obtido por meio de vários métodos, incluindo:</p>
<list list-type="simple">
<list-item><label>–</label> <p><bold>Handgrip:</bold> O paciente aperta um dinamômetro de preensão manual, que gera contrações musculares isométricas sustentadas. Este método induz aumento da resistência vascular sistêmica.</p></list-item>
<list-item><label>–</label> <p><bold>Constrição de membros</bold>: Envolve aplicar pressão externa aos membros usando manguitos ou faixas para criar uma resistência controlada contra o fluxo sanguíneo. O aumento resultante na resistência sistêmica oferece um desafio de pós-carga mensurável.</p></list-item>
</list>
<p>Esses métodos podem ser usados individualmente ou combinados. O desafio de pós-carga pode oferecer vantagens distintas sobre o exercício dinâmico padrão, uma vez que induz uma sobrecarga hemodinâmica controlada sem aumentar significativamente as frequências cardíaca e respiratória. Isso leva a menos ruído nos sinais ecocardiográficos, aumentando assim a precisão da imagem de deformação avançada.</p>
<p>No entanto, é importante reconhecer as diferenças fundamentais entre o exercício dinâmico padrão e o desafio pós-carga. O exercício dinâmico padrão induz principalmente uma "perturbação hemodinâmica anterógrada", que aumenta sequencialmente a pressão venosa central, a pressão da artéria pulmonar em cunha, a pré-carga atrial esquerda e o gradiente átrio esquerdo-ventrículo esquerdo (AE-VE), aumentando a onda E mitral. Esse tipo de estresse desafia o VE a aumentar a velocidade de relaxamento (e&apos;), avaliando, assim, a reserva diastólica.</p>
<p>Em contrapartida, um desafio de pós-carga cria uma "uma perturbação hemodinâmica retrógrada", aumentando a resistência sistêmica, o que reduz a velocidade de relaxamento do VE. Isso resulta em velocidades e&apos; mais baixas e um gradiente AE-VE diminuído (onda E mitral mais baixa). Consequentemente, características ecocardiográficas como a razão E/e&apos; exibem comportamento diferente sob esse tipo de estresse, geralmente sem um aumento significativo. A resposta ventricular normal ao aumento da pós-carga geralmente envolve uma redução na velocidade e na extensão da contração ventricular, levando a um aumento compensatório na pré-carga e à ativação do mecanismo de Frank-Starling para contração cardíaca. Notavelmente, a função longitudinal do VE, avaliada por meio de imagens de deformação, parece particularmente sensível a essas alterações de contração.<sup><xref ref-type="bibr" rid="B4">4</xref></sup></p>
<p>Estudos que investigam o GLS durante o estresse hemodinâmico induzido pelo desafio de pós-carga podem oferecer informações valiosas.<sup><xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B22">22</xref>-<xref ref-type="bibr" rid="B24">24</xref></sup> Dados recentes destacaram a disfunção miocárdica induzida pelo aumento da pós-carga em pacientes com ICFEp, apesar de apresentar GLS em repouso preservado (<xref ref-type="fig" rid="f8">Figura 3</xref>).<sup><xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B4">4</xref></sup></p>
<fig id="f8">
<label>Figura 3</label>
<caption><title>O comportamento do GLS durante o desafio de pós-carga e o aumento da disfunção sistólica mediada por pós-carga. ICFEp: Insuficiência cardíaca com fração de ejeção preservada.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-pt-gf03.tif"/>
</fig>
<p>Portanto, o desafio de pós-carga apresenta características que o configuram como modalidade de escolha para estudar as alterações da deformação miocárdica e do acoplamento ventrículo arterial durante o estresse.</p>
</sec>
<sec>
<title>Deformação ventricular esquerda além do GLS: o papel da dispersão mecânica</title>
<p>O GLS mede a quantidade média de contração longitudinal realizada pelo VE desde o início da contração isovolumétrica até o final da ejeção ventricular. Consequentemente, informações valiosas sobre outras fases do ciclo cardíaco, como relaxamento isovolumétrico, não são capturadas pelo GLS.<sup><xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref></sup> Embora o GLS ofereça uma quantificação precisa da contração ventricular, ela não explica qualitativamente como a contração é realizada.</p>
<p>A dispersão mecânica (MD) é uma característica de deformação que expressa o grau de heterogeneidade temporal da contração, servindo como um indicador de dissincronia mecânica (<xref ref-type="fig" rid="f9">Figura 4</xref>).<sup><xref ref-type="bibr" rid="B25">25</xref></sup> A dissincronia foi estabelecida como uma característica importante da contração miocárdica anormal no contexto de condições como insuficiência cardíaca com FE reduzida,<sup><xref ref-type="bibr" rid="B26">26</xref></sup> doença arterial coronária,<sup><xref ref-type="bibr" rid="B27">27</xref></sup> hipertrofia e ICFEp.<sup><xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref></sup></p>
<fig id="f9">
<label>Figura 4</label>
<caption><title>O papel da MD. À esquerda, o paciente tem um GLS anormal e baixa MD. À direita, um paciente com o mesmo valor de GLS, mas exibindo uma alta MD. GLS: deformação longitudinal global.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-pt-gf04.tif"/>
</fig>
<p>A justificativa para usar esse índice em ICFEp é que, teoricamente, uma contração cardíaca heterogênea, conforme constatada por uma MD alta, leva a contrações regionais que não encontram a força recíproca das paredes cardíacas opostas. Assim, parte da deformação cardíaca não será traduzida em uma força efetiva para expelir sangue em direção à aorta. Além disso, a dissincronia afetará o acoplamento atrio-ventricular e ventriculo-arterial. Esse duplo impacto no desempenho do VE torna o coração mais propenso a maiores aumentos na pressão do átrio esquerdo (AE) durante adaptações ao exercício, como aumento da pré-carga e taquicardia. Assim, no contexto de um GLS relativamente preservado, informações sobre a sincronicidade da contração podem ajudar a explicar os comprometimentos sutis observados em um subconjunto de pacientes com ICFEp.</p>
<p>Dados recentes sugerem que a MD está mais associada à capacidade de exercício em pacientes com pré-ICFEp e ICFEp quando comparada ao GLS e outros componentes do escore HFA-PEFF, além de ser capaz de fornecer novas informações sobre como o coração pode ser mais propenso ao aumento acentuado nas pressões de enchimento durante o exercício que caracteriza essa síndrome.<sup><xref ref-type="bibr" rid="B25">25</xref></sup></p>
<p>Atualmente, não existe um ponto de corte preciso para MD, mas dados recentes indicam que valores maiores que 65 ms têm alta especificidade para identificar indivíduos com alta probabilidade de ICFEp.<sup><xref ref-type="bibr" rid="B25">25</xref></sup></p>
</sec>
<sec>
<title>Imagem de deformação para fenotipagem da síndrome da ICFEp</title>
<p>Os padrões de diferentes índices de imagem de deformação podem ajudar a identificar fenótipos específicos dentro da ICFEp.<sup><xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B30">30</xref></sup> Pacientes com ICFEp e GLS reduzido (ICFEp-rLS) apresentam disfunção contrátil, bem como anormalidades fazer miocárdio ventricular.</p>
<p>Por outro lado, 18-48% dos pacientes com ICFEp mantêm o GLS preservado (ICFEp-pLS), mas apresentam outros problemas fisiopatológicos, como disfunção atrial e doença vascular pulmonar.<sup><xref ref-type="bibr" rid="B30">30</xref></sup> Neste grupo, a deformação atrial esquerda (StrainAE) é um biomarcador promissor para ICFEp e miopatia do AE, melhorando as informações diagnósticas e prognósticas.<sup><xref ref-type="bibr" rid="B31">31</xref></sup> Um StrainAE reduzido em pacientes com ICFEp-pLS indica comprometimento significativo do AE devido à cardiomiopatia atrial, desafiando a noção tradicional que vincula a doença do AE somente à disfunção diastólica do VE. A combinação de GLS e StrainAEr para fenotipagem de ICFEp oferece uma compreensão mais abrangente dos comprometimentos cardíacos nesses pacientes<sup><xref ref-type="bibr" rid="B11">11</xref></sup> (<xref ref-type="fig" rid="f10">Figura Central</xref>).</p>
<fig id="f10">
<caption><title>Estratégia de fenotipagem para ICFEp. Com base na deformação ventricular esquerda, existem dois fenótipos distintos de ICFEp: ICFEp com função sistólica longitudinal reduzida (ICFEp-rLS) e ICFEp com função sistólica longitudinal preservada (ICFEp-pLS). A integração da fase de reservatório do strain esquerdo (StrainAEr) é sugerida para introduzir uma dimensão abrangente que aborde deficiências tanto no VE quanto no AE. Além disso, a inclusão potencial de MD poderia refinar ainda mais a estratificação. ICFEp: Insuficiência Cardíaca com Fração de Ejeção Preservada; VE: ventrículo esquerdo; AE: átrio esquerdo; StrainAEr: reservatório de deformação do átrio esquerdo; MD: dispersão mecânica; GLS: Deformação Longitudinal Global; ICFEP-rLS: ICFEp com função sistólica longitudinal reduzida.</title></caption>
<graphic xlink:href="2675-312X-abcimg-37-04-e20240104-pt-gf05.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusions">
<title>Considerações finais</title>
<p>Apesar da FE preservada, o comprometimento da função sistólica, conforme observado pelas anormalidades de GLS e MD, e o comprometimento da função do reservatório atrial, demonstrado por uma redução na StrainAE, seja isolado ou em associação, corroboram o diagnóstico de ICFEp. Da mesma forma, a ausência de aumento do GLS durante o esforço físico pode ser um sinal de ICFEp. Além disso, é importante interpretar essas medidas em conjunto com outros dados ecocardiográficos. Um aumento em E/e&apos; acima de 15, isolado ou em combinação com um aumento na pressão sistólica da artéria pulmonar acima de 60 mmHg durante o exercício no cicloergômetro, são fortes indicadores de aumento das pressões de enchimento do VE com o esforço.<sup><xref ref-type="bibr" rid="B12">12</xref></sup> Apesar disso, ainda há uma escassez de conhecimento sobre como as informações hemodinâmicas fornecidas pelo Doppler devem ser interpretadas juntamente com as medidas de deformação. Finalmente, ainda é preciso compreender melhor como interpretar esses achados em conjunto com as muitas variáveis clínicas e laboratoriais que podem ser modificadas em pacientes com ICFEp. Desenvolver escores que integrem todas essas variáveis em diferentes fenótipos de ICFEp seria clinicamente relevante.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure" id="fn4">
<label>Fontes de Financiamento</label>
<p>O presente estudo não teve fontes de financiamento externas.</p></fn>
<fn fn-type="other" id="fn5">
<label>Vinculação Acadêmica</label>
<p>Não há vinculação deste estudo a programas de pós-graduação.</p></fn>
<fn fn-type="other" id="fn6">
<label>Aprovação Ética e Consentimento Informado</label>
<p>Este artigo não contém estudos com humanos ou animais realizados por nenhum dos autores.</p></fn>
</fn-group>
</back>
</sub-article>
</article>
